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Abstract
Background: In order to achieve universal health coverage, the government of Anambra State, southeast Nigeria
has distributed free Long-lasting Insecticide treated Nets (LLINs) to the general population and delivered free
Artemisinin-based Combination Therapy (ACT) to pregnant women and children less than 5 years. However, the
levels of coverage with LLINS and ACTs is not clear, especially coverage of different socio-economic status (SES)
population groups. This study was carried out to determine the level of coverage and access to LLINs and ACTs
amongst different SES groups.
Methods: A questionnaire was used to collect data from randomly selected households in 19 local government
areas of the State. Selected households had a pregnant woman and/or a child less than 5 years. The lot quality
assurance sampling (LQAS) methodology was used in sampling. The questionnaire explored the availability and
utilization of LLINs and ACTs from 2394 households. An asset-based SES index was used to examine the level of
access of LLINS and ACTs to different SES quintiles.
Results: It was found that 80.5 % of the households had an LLIN and 64.4 % of the households stated that they
actually used the nets the previous night. The findings showed that 42.3 % of pregnant women who had fever within
the past month received ACTs, while 37.5 % of children <5 years old who had malaria in the past month had received
ACTs. There was equity in ownership of nets for the range 1–5 nets per household. No significant SES difference was
found in use of ACTs for treatment of malaria in children under five years old and in pregnant women.
Conclusions: The free distribution of LLINs and ACTs increased household coverage of both malaria control
interventions and bridged the equity gap in access to them among the most vulnerable groups.
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Background
Malaria is the most significant public health problem in
Nigeria [1,2]. The disease is responsible for 60 % out-
patient visits to health facilities, 30 % childhood death,
25 % of death in children under one year, 11 % maternal
death [3]. The financial loss due to malaria annually is
estimated to be about 132 billion Naira in form of
treatment costs, prevention, loss of man-hours etc, yet, it
is a preventable and treatable disease [3].
The sixth Millennium Development Goal (MDG 6),
which is to combat HIV/AIDS, Malaria and other dis-
eases, has among its second target to have halted by
2015 and begun to reverse the incidence of malaria. Two
of the indicators for this goal are the proportion of chil-
dren under 5 sleeping under insecticide-treated bed nets
and the proportion of children under 5 with fever who
are treated with appropriate anti-malarial drugs [4].
Malaria control in Nigeria anchors on the multi-pronged
global strategies for malaria control. These include prompt
and effective case management (early diagnosis and
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combination therapy); intermittent preventive treatment of
malaria in pregnancy (IPTp); Integrated Vector Manage-
ment including use of Long-lasting Insecticide Treated
Nets (LLINs); Indoor Residual Spraying (IRS) and Environ-
mental Management [3].
ITNs are a key prevention tool that have been found to
reduce uncomplicated malaria in children by 51 % and
decrease all-cause mortality by 18 % in children aged 1–
59 months [5]. By preventing malaria, LLINs reduce the
need for treatment and the pressure on health services
[6]. The MDG report of 2011 indicated a remarkable
surge in the production, purchase and distribution of in-
secticide-treated mosquito net globally, and particularly
in Africa, with a marked increase in ownership and use
among children, that were attributed to widespread na-
tionwide campaigns for the distribution of free nets [7].
The Nigerian National Demographic and Health Sur-
vey (NDHS) of 2008 recorded 8 % household coverage
with insecticide-treated nets (ITNs) and this was seen to
increase with wealth quintiles [8]. Some studies have
highlighted poverty as a barrier to scaling up of ITN in
Nigeria since a large proportion of the population still
live under a dollar per day [9,10]. Even when mass distri-
bution of free nets is attempted, the limited resources of
the country considering the very large population, makes
sustainability almost impossible without continuous sup-
port from donor agencies [10].
Following the extensive resistance to chloroquine and
sulphadoxine-pyrimethamine in Nigeria, ACTs were
introduced in 2005 as the first line anti-malaria drug of
choice [11]. Three years after this introduction, the
NDHS showed that an average of 2.5 % of children under
five years who had fever were treated with ACTs and this
increased significantly with wealth quintile and mother’s
education [8]. Cost and frequent stock out of ACTs in
public health facilities have been recorded as the major
reasons for low coverage rates [12]. The National policy
on diagnosis and treatment of malaria states that the
recommended medicines for treatment of uncomplicated
malaria in all age groups are ACTs, except for children
<5 kg and pregnant women in first trimester, and that
all medicines provided by The Federal Government to
public health facilities shall be at no cost to the clients
[13]. Whilst limiting as far as possible the inappropriate
use by those who do not have malaria, there is a need to
ensure that these commodities reach those who are most
at-risk [14].
In order to improve access to LLINs and ACTs, the
government of Anambra State, southeast Nigeria under
the National Malaria Control Booster Programme
embarked on free mass distribution LLINs and provision
of free ACTs in public primary health facilities, with the
aim of ensuring wide-scale and equitable deployment of
LLINs and ACTs amongst other malaria control tools in
the state. The LLINs were distributed through routine
distribution methods and campaigns and ACTs were
supplied to primary and secondary public health facil-
ities. The State Malaria Control Booster programme
started distributing LLINs and ACTs to pregnant women
and children <5 years since January 2010, but the level
of coverage of the programme, especially as it relates to
different socio-economic status (SES) groups is not clear.
Though infrequently conducted, household surveys are
the preferred means of assessing whether or not suffi-
cient LLINs and ACTs have been delivered and utilized
to cover population at risk of malaria, and to provide up
to date estimates [15].
The paper provides new information about the level of
coverage that a free distribution of LLINs and ACTs was
able to achieve. The findings will be useful for decision-
makers to understand the level of coverage that free mal-
aria control tools can achieve and to develop strategies
that will ensure proper coverage of these interventions.
Methods
Study area and design
The study was conducted in Anambra state, south-east
Nigeria in April 2011. Anambra state has a total of 21
local government areas (LGAs) and a population of
4,182,032 inhabitants whose major occupations are farm-
ing (75 %), trading and fishing [16]. Malaria transmission
is stable all year round but higher rates are experienced
during the rainy months. Pregnant women and children
are the most affected by malaria in the state. There are
about 382 primary health centers (PHCs), owned and
managed by Local Government Areas (LGAs) in the
State.
Lot quality assurance sampling (LQAS) method was
used [17]. 19 clusters were selected from each of the 21
LGAs. For the purpose of this study, a cluster was
defined as a group of households served by a public
health facility that provides primary level of care. In each
of the clusters, households were listed, a total of six
households that met the inclusion criteria of having a
pregnant woman and/or a child less than five years living
in the house were picked by simple random sampling,
and only one respondent was interviewed in each house-
hold. A total of 2394 households were selected but the
sample size was increased to 2500 (Figure 1). Question-
naires were administered to a random selection of
respondents who were in order of preference, pregnant
women, mothers of children less than five years old, fe-
male caregivers, male caregivers. In the absence of an in-
formant, the household was replaced by simple random
sampling with another household.
Data was collected from the respondents by trained inter-
viewers using a questionnaire. Information was collected
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household members; availability and use of LLINs; source
of LLINs; use of ACTs with emphasis on pregnant women
and children less than five years old; health facility visited
for treatment of malaria; and cost of treatment of malaria
in pregnant women and children <5 years. Information
was also collected on the household food expenditure and
assets.
Data analysis
Data was analyzed using the statistical package for social
sciences version 15 (SPSS 15). The questionnaires were
coded for identification and each one was entered into
the system with its code. Data entry was done once by
the data clerks and double checked by the researchers.
Frequencies were calculated for all the variables to deter-
mine missing values and further clean the data.
Frequencies were calculated for household ownership
and utilization of LLINs to determine its coverage. Fre-
quencies were also calculated for utilization of ACTs for
treatment of fever in pregnant women and children less
than five years old. The socio-economic status (SES) of
the households was determined using an-asset based
index, which was computed using principal components
analysis. The SES index was used to divide the sample
into quintiles. Ownership and utilization of LLINs, as
well as the utilization of ACTs were disaggregated into
SES quintiles. Where appropriate, chi square test was
used for tests of significance for proportions of categor-
ical variable, and all test of significance were done based
on a p-level of 0.05.
Ethical approval
Ethical approval was obtained from the Health Research
Ethics Committee of University of Nigeria Teaching Hos-
pital, Enugu State, Nigeria.
Results
Data was collected from 2401 respondents giving a re-
sponse rate of 96 %.
Table 1 shows the results of demographic characteris-
tics of the respondents. 2112 (88 %) were females, 1348
(56.2 %) were within age group 25–34 years with mean
age of 31.8 years. The results also showed that 898
(37.1 %) of our respondents were pregnant women with
mean gestational age of 5.6 months (SD 2.0). 2234
(95.8 %) of households surveyed had at least one child
under five years old, and 1578 (65.6 %) of the surveyed
households had between 5 and 10 members living in the
house (Table 1).
Table 2 shows that 1932 (80.5 %) of households had
LLINs and the mean number of nets per household was
two. On source of LLINs the study showed that 2187
(81.1 %) of households who had LLINs received the nets
during the free distribution while 77 (3.2 %) purchased
theirs. A small proportion of the respondents had got
their LLINs from relatives, friends or during election
campaigns. Of the 469 (19.5 %) of households that did
not have LLINs, reasons for not having included: didn’t
receive during free distribution- 369 (78.7 %); don’t know
21 Local Government Areas   
 399 clusters
2394 households
Figure 1 Flowchart showing sample selection process from
local government areas to households.
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LLINs- 64 (13.6 %); don’t think it is important 49
(10.4 %); don’t like it- 32 (6.8 %). Other reasons which
made up the rest (46/469 i.e. 9.8 %) were: new to place
or just moved to the place; left net in former place of
residence; was not pregnant during period of distribu-
tion; was not around during distribution; there was a lot
of rush during distribution; nets got damaged; shared to
women alone; not necessary- mosquitoes don’t bite me, I
have a plant that kills insects, mosquitoes are not in this
village.
For utilization of the LLINs, Table 2 shows that 1546
(64.4 %) of the households had members who had slept
under their LLINs the previous night, and in 964 (65 %)
of these households, all members slept under the nets.
Of those who had not used nets the previous night,
based on a multiple response question on reasons for
non use, 454 (66 %) said it made them sweat, while 43
(6.3 %) said LLIN is not a necessary preventive measure
for malaria (Table 2).
The result also shows that 965 (40.2 %) of surveyed
households had at least one case of fever in the past one
month, with the highest distribution of fever, 446
(46.2 %), being in children under five years. The propor-
tions of children under five and pregnant women with
fever are 446/2234 (20 %) and 227/898 (25.3 %) respect-
ively. Only 96 (42.3 %) of the pregnant women with fever
and 167 (37.5 %) children under-five years with fever
sought care at a primary health care facility. Of those
treated, 45.7 % of pregnant women and 38.7 % of chil-
dren under-five years were treated with ACTs (Table 3).
Table 4 shows that there is equity in ownership of
LLINs for the range 1–5 nets per household, but the
ownership of more than 5 LLINs is higher among the
rich. Also, there was significant difference across SES
quintiles among those who received nets during
immunization, free distribution and those who pur-
chased (Table 4).
Table 5 shows the SES differences in the utilization of
antimalarials for prevention and treatment of malaria by
pregnant women and children less than five years across
wealth quintiles. There was no significant difference in
the utilization of antimalarials for treatment of malaria
in children <5 years and in pregnant women but for
‘others’ in prevention of malaria among pregnant women.
Discussion
Although the finding of 80.5 % LLINs coverage rate in
the households sampled meets the RBM target and is a
significant improvement on the NDHS of 2008, it falls
short of the country’s roadmap implementation target
for 2010, which is a 95 % coverage rate [8,18]. According
to the 2008 NDHS report, 8 % of surveyed households
owned at least one insecticide treated net (ITN), 3 %
owned >1 ITN, and the average number of ITNs per
Table 1 Socio-demographic characteristics of respondents
Characteristics Proportions
n( % )
Sex
￿Females 2112 (88)
￿Males 287 (12)
Age (years)
￿15–24 313(13.1)
￿25–34 1347(56.2)
￿35–44 600(25.1)
￿45–54 106(4.4)
￿55–64 24(1.0)
￿65–74 5(0.2)
Mean Age (years)=31.8(SD 7.3)
Number of pregnant women 898(37.1)
Mean Gestational Age (months)=2.1(SD 2.9)
Number of households with at least one child <5 years 2300 (95.8)
Number of households with no child <5 years old 101(4.2)
No. of People in Households (N=2397)
￿<5 808(33.6)
￿5–10 1574(65.6)
￿>10 19(0.8)
Table 2 Ownership and utilization of LLINs by members
of households and reasons for non-utilization
Variables Proportions
n(%)
Number of households that have a LLIN 1932 (80.5)
Mean number of LLINs per household=2
Number of households where a LLIN was used the
previous night
1244 (64.4)
Number of households in which a LLIN was used the
previous night by: (N1=1244)
￿All household members 784 (63.0)
￿Pregnant women only 83 (6.7)
￿Children under five years only 377 (30.3)
Reasons for non-use of LLINs by households
(N2=688)
￿Forgot to use it 21 (3.1)
￿Makes me sweat 454 (66.0)
￿Not necessary 43 (6.3)
￿Mosquitoes still bite me 51 (7.5)
￿Skin irritation 65 (9.4)
￿Other reasons 65 (9.4)
N1 represents number of households where a long-lasting insecticide treated
net was used the previous night which is 1244 households.
N2 represents number of households where a long-lasting insecticide treated
net was not used the previous night, which is 688 households.
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households in the Southern zones and increased with
wealth quintiles [8]. In the NMCP, free LLINs are given
only to pregnant women and children <5 years and the
target of RBM is for 80 % coverage of LLINs by 2010.
This improvement, however, can be attributed to the
State-wide free LLINs distribution that took place about
a year ago, since 81.1 % of those who owned LLINs
had obtained them during the free distribution exercise.
The shortfall could be accounted for by the abrupt halt
in the free distribution exercise since majority of the
respondents who did not have the nets were absent at
the time of distribution. Lack of funding and the size of
at risk population to be reached have been identified as
major restricting factors to complete coverage of LLINs
[12].
Household ownership of LLINs was found to be equit-
ably distributed across all quintiles as opposed to the
2008 NDHS which found that households in higher
wealth quintiles significantly owned ITNs more than
those in lower quintiles [8]. The implication of this find-
ing is that free LLINs distribution minimized inequalities
in ownership of LLINs by enabling households in the
poorest wealth quintiles to access this malaria control
strategy. Other studies in African countries have revealed
similar findings of decreased inequity following distribu-
tion of free ITNs [9,19-22]. However, we find that there
is significant equity difference in the ownership of more
than 5 LLINs per household. Controversy still exists in
this aspect as some studies have found that lower wealth
quintiles owned more number of nets per household
than higher ones, depending on the setting of the study,
rural or urban [11,19].
Over half of the households in this survey had mem-
bers who slept under the LLINs the previous night. This
is an improvement on the 2008 NDHS which found
49.8 % and 44.4 % utilization rates among children
<5 years and pregnant women respectively, but it still
falls short of the RBM target for 2010 which is an 80 %
utilization rate [1,8]. Among our respondents, the com-
monest reason for non-use of LLINs was that it made
them sweat( 66 %), as opposed to a study in 2008, where
71.4 % of non-use was as a result of lack of awareness
about LLINs and only 3.4 % for reason of sweating [23].
This difference in reason for non-use could be explained
by the increased utilization rates, since only those who
use nets can experience sweating under them. Although
a positive association can be drawn between LLIN own-
ership and use, we cannot from our study conclusively
say that there is a causal relationship. Several studies in
Africa have also found a positive relationship between
LLINs ownership and use among households [19-22].
Table 3 Drugs used in primary health care facilities for
treatment of malaria in pregnant women and children
less than five years
Drugs used for treatment of malaria Proportion of people
treated n (%)
1. Pregnant women (N=380)
Artemisinin-based combination therapy (ACT) 174 (45.7)
Chloroquine 1 (0.4)
Quinine 8 (2.2)
Sulphadoxine-Pyrimethamine (SP) 129 (33.9)
Artesunate monotherapy (AM) 4 (1.1)
Others 64 (16.7)
2. Children less than five years (N =838)
Artemisinin-based combination therapy 324 (38.7)
Chloroquine 127 (15.2)
Quinine 27 (3.2)
Sulphadoxine-Pyrimethamine 86 (10.2)
Artesunate monotherapy 28 (3.3)
Others 246 (29.4)
Others include herbal medicines and concoctions; unknown mixture of tablets
and injections; paracetamol; and paludrine.
Table 4 Socioeconomic differences in the ownership and source of LLINs
Variables Q1 n(%) Q2 n(%) Q3 n(%) Q4 n(%) Q5 n(%) Q1:Q5
(equity ratio)
Chi square
(p value)
Availability of LLINs in household 365(78) 388(83) 393(84) 380(81) 359(77) 1.02 12.38(0.15)
No. of LLINs per household
1–5 362(99.2) 385(99) 389(99) 369(97) 344(96) 1.05
>5 3(0.8) 3(1) 4(1) 11(3) 15(4) 0.15 157.29(0.0)
Source of LLIN
During immunization 38 (11) 56 (14) 70 (18) 60 (18) 79(21) 0.52 15.92(0.003)
Antenatal clinics 79 (22) 78 (20) 88 (22) 60 (18) 67(18) 1.22 7.78(0.100)
Free distribution 288 (78) 295 (75) 313 (80) 330 (87) 304(89) 0.98 17.21(0.002)
Purchased LLIN 13(4) 3 (1) 15 (4) 10 (3) 19(5) 0.80 12.78(0.012)
Others 6 (1.7) 1 (0.3) 4 (1) 4 (1) 1(0.3) 5.67 6.53(0.160)
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of malaria, the utilization rates falls far short of the RBM
target of 80 % by 2010 [24]. There seems to be decrease
in utilization of ACTs from our study when compared to
a cross-sectional multi country survey on coverage rate
of ACTs which found 52 % coverage rate among children
in Nigeria in 2007 [25]. This shortfall could be explained
by the inconsistencies in the delivery of ACTs to the
public health facilities which is being experienced in
Anambra State. A quality assessment survey done by the
Health Policy Research Group in November 2010
showed that 54.4 % of the primary health care facilities
in Anambra State had been out of stock for ACTs for a
period of at least 3 months [26]. Studies in Africa have
found that a large proportion of patients seek care at
public health facilities first, and when they cannot access
this care they resort to sub standard care for the reason
of cost [27]. This was consistent with our finding of the
continued use of less efficacious antimalarials like
chloroquine and Sulphadoxine-pyrimethamine which
have high levels of drug resistance in Africa. Of greater
concern is the use of artemisinin monotherapy (AM).
Considering that the cost of one adult dose of the first
choice ACT (Artemisinin-Lumefantrine) was calculated
to be US$10.3 [28], which is high especially where the
mean total food expenditure as found in our survey is
6,785.23 (US$45.2), and the potential threats of drug re-
sistance which AM poses to the only currently proven
efficacious antimalarial (ACTs), there is need to scale-up
free ACTs.
Despite the low utilization rate of ACTs, there was
equity in access among the most vulnerable group, chil-
dren less than five years old and pregnant women.
Inconsistencies in delivery of free ACTs to public health
facilities and cost of purchasing them when free ones are
not available have been identified as the two major bar-
riers to scaling up ACTs coverage rate among vulnerable
groups. Subsidizing ACTs by 90 % was found to increase
the proportion of consumers purchasing them for a sig-
nificantly higher number of under-fives from 1 % to
44 % in one year in Tanzania [29]. The fact that ACTs
were provided free of charge in the public health facil-
ities could explain the bridge in equity gap in access be-
tween the rich and the poor.
Free distribution of LLINs significantly increased its
coverage rate and reduced inequities in ownership of
nets across wealth quintiles. A positive association can
be drawn between nets ownership and use. Distribution
of free LLINs to all households is likely to achieve the
goal of combating malaria regardless of socioeconomic
status.
The free distribution exercise did not significantly im-
prove ACT coverage among vulnerable groups, although
inequities do not exist in the access to ACTs by the most
vulnerable group, children less than five years. Sustain-
ability and cost have been identified as major limiting
factors to ACTs coverage.
Success of malaria control requires strong, sustained
political and budgetary commitment. Policy makers and
parliamentarians need to support the malaria control
programs and health systems in their countries by pro-
viding and coordinating the necessary resources, espe-
cially financial; by helping to resolve bottlenecks in
countries (e.g. taxes and tariffs, administrative or regula-
tory procedures); and coordinating all partners active in
the country to reach rapidly the universal coverage targets.
Table 5 Socioeconomic differences in the utilization of antimalarials by pregnant women
Antimalarials used for treatment of fever Q1 (%) Q2 (%) Q3 (%) Q4 (%) Q5 (%) Q1:Q5 Chi square
(p value)
Children less than five years
ACTs 9(28) 13(29) 13(33) 29(43) 27(26) 1.1 5.97(0.20)
Chloroquine 0(0) 1(2) 0(0) 0(0) 2(2) 0 2.85(0.58)
Quinine 0(0) 0(0) 1(2.6) 1(1.5) 1(1) 0 1.83(0.77)
Sulfadoxine-pyrimethamine 7(21) 11(24) 8(21) 13(19) 22(21) 1 0.42(0.98)
Artesunate monotherapy 1(3) 2(4) 5(13) 4(6) 9(9) 0.3 3.69(0.45)
Others 5(15) 4(9) 7(18) 7(10) 6(6) 2.5 5.61(0.23)
Pregnant women for treatment of malaria
ACTs 10(27) 16(28) 15(34) 36(48) 42(38) 0.71 7.66(0.11)
Chloroquine 0(0) 0(0) 0(0) 0(0) 1(1) 0.0 1.94(0.75)
Quinine 1(3) 0(0) 1(2.3) 1(1.3) 2(2) 1.49 1.45(0.84)
Sulfadoxine-pyrimethamine 10(27) 21(37) 14(32) 16(21) 30(27) 0.99 4.21(0.38)
Artesunate monotherapy 0(0) 1(2) 0(0) 1(1) 1(1) 0.0 1.32(0.86)
Others 10(27) 5(9) 11(25) 12(16) 6(5) 4.95 18.09(0.001)
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havior change communication approach will be an im-
portant tool to address the 10 % of respondents who still
think use of LLINs is not an important malaria preven-
tion strategy.
The main limitation of the study is that it is cross-
sectional, not a randomized controlled trial. Therefore,
strong cause and effect relationships cannot be estab-
lished. The study was conducted less than one year after
the roll out of free LLINs, so the increased coverage and
use may be transient, and there is likelihood that it may
drop with time as ITNs wear out. There may be a need
for further studies with longer follow up periods to as-
certain the sustainability of current coverage rates.
However, the strength of this study is that respondents
(households) were selected randomly and therefore make
a good representation of the study population. This im-
plies that the results of the study will be reproduced if
the whole population is used.
This study provides some information on how the na-
tional and international target of 80 % coverage and use
of LLINs might be achieved, as well as reducing inequal-
ity through free distribution. Further research with an
ideal randomized controlled design with sufficient house-
holds and time for follow up, should clarify the possible
long-term impact of changing distribution policies from
cost-sharing schemes to free distribution.
Conclusion
The free distribution of LLINs and ACTs increased
coverage of both malaria control interventions compared
to previous surveys (NDHS, 2008). Coverage rate of
LLINs slightly exceeded the Roll Back Malaria target, but
this was not so for coverage of ACTs. It also bridged the
equity gap in access to these malaria control interven-
tions. Although there was increase in ACTs coverage
compared to figures from 2008 National Demographic
and Health Survey (NDHS) which found a 2.4 % cover-
age rate for the country, there needs to be a sustained ef-
fort to ensure that the rate of increase is maintained till
the RBM target is achieved.
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